Class IIIReported 2025-11-05
Everolimus tablets 2.5 mg, 28 tablets (each carton contains 4 blister strips with 7 tablets each), Rx only, Manufactured by: Par Pharmaceutical Chestnut Ridge, NY 10977 NDC# 49884-119-91
Recalled by Endo USA, Inc.
Reason for Recall
Failed Impurities/Degradation Specifications: Out of specification for impurity IP-C.
Advertisement
Recall NumberD-0142-2026ClassificationClass IIIStatusOngoingCategorydrugInitiated2025-10-10Reported2025-11-05DistributionNationwide within the United StatesCode InfoLot #: 550172201, Exp. Date JAN-26; 550184801, Exp. Date MAR-26; 550204001, Exp. Date JUL-26Source: openFDA enforcement report. WhichRecall is not affiliated with the FDA. See our disclaimer.